NEWS
Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility
Scorpius Holdings (NYSE American: SCPX) has successfully executed its first current Good Manufacturing Practice (cGMP) microbial batches at its San Antonio facility. This milestone marks the beginning of Scorpius' support for manufacturing programs through clinical manufacturing, with potential for future commercial activities. The company has attracted significant interest, resulting in a substantial backlog of client program bookings.
CEO Jeff Wolf emphasized that this achievement demonstrates Scorpius' robust systems and commitment to U.S.-based cGMP activities. The company is poised to execute additional cGMP activities throughout the remainder of the year, reinforcing its position as a leader in clinical scale microbial manufacturing.
CEO Jeff Wolf emphasized that this achievement demonstrates Scorpius' robust systems and commitment to U.S.-based cGMP activities. The company is poised to execute additional cGMP activities throughout the remainder of the year, reinforcing its position as a leader in clinical scale microbial manufacturing.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2311Followers
105Following
24KVisitors
Follow